Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • G7 to explore caps on energy prices to curb Russian revenues
    • Boris Johnson wins Commons vote on bill to rip up N Ireland protocol
    • Nato to increase forces on high alert to 300,000
    • Russia claims responsibility for Kremenchuk mall strike
    • Russian missile strike on Ukrainian shopping mall draws outcry
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • G7 to explore caps on energy prices to curb Russian revenues
    • Why the US could be the real winner in the energy wars
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • Donald Trump’s plans for Spac deal suffer further blow after subpoenas
    • US company spending on private jets for personal use hits 10-year high
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Luxottica founder Leonardo Del Vecchio dies aged 87
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • Donald Trump’s plans for Spac deal suffer further blow after subpoenas
    • US company spending on private jets for personal use hits 10-year high
    • ExxonMobil chief predicts continuing surge in oil markets
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates: US to announce new military commitments during Nato summit
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • France’s approval of crypto exchange Binance branded ‘incomprehensible’ by MEP
    • Live news updates from June 27: G7 to impose new sanctions on Russian arms industry, Property developer Evergrande faces winding-up petition
    • Time is ripe to snap up bargains, says debt investor Howard Marks
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Young men are slipping quietly through the economy’s cracks
    • Why the US could be the real winner in the energy wars
    • The high cost of producing cheap food
    • Crisis looms if the ECB’s new tool comes up short
    • Grim times lie ahead for UK as inflation combines with low growth
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • What’s a good (and bad) way to leave your job?
    • If you want to be more likeable, try showing more stress
    • ‘Exactly how much virtue do you really want to signal?’
    • JSR’s Eric Johnson: ‘I encourage people to tell me exactly how they think’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Inside the secret, often bizarre world that decides what porn you see
    • What can the past tell us about Bitcoin’s future?
    • The future of farming: how to feed a troubled world
    • A pilot’s guide to beating jet lag
    • Sunday at Glastonbury — a next-level performance from Kendrick Lamar closes the festival
  • HTSI
  1. Companies
  2. Health
  • Health Care
  • Pharmaceuticals
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Health sector

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 28 June, 2022
    Anjana Ahuja
    Monkeypox makes pledges of pandemic solidarity look hollow

    The global south has once again been abandoned in its quest for vaccines

    1 hour ago
  • Tuesday, 28 June, 2022
    Boots UK Ltd
    Walgreens halts sale of Boots chain citing tougher financial conditions

    Owner of UK pharmacy and beauty group blames market turmoil for bids below its expectations

  • Tuesday, 28 June, 2022
    Reproductive rights
    Abortion pills in demand after reversal of Roe vs Wade

    Remote providers report a leap in requests as conservative US states roll out a number of restrictions

  • Monday, 27 June, 2022
    Croda International PLC
    US government to invest up to $75mn in new Croda factory

    Washington seeks to expand domestic production of crucial component of mRNA vaccines

  • Monday, 27 June, 2022
    Covid-19 vaccines
    Pause in medication would improve Covid jab response for millions, study shows

    Short break in immune suppression treatment improves antibody production after vaccination while doing little harm

  • Monday, 27 June, 2022
    Kristin Lyerly
    Abortion providers are doing all we can — but we can only do so much

    The repeal of Roe vs Wade is forcing our patients to look at options from travel to online provision to carrying undesired pregnancies

  • Monday, 27 June, 2022
    CareTech Holdings PLC
    CareTech to be taken private by founders in £1.2bn deal

    UK social care provider has benefited from rising demand during the pandemic

  • Saturday, 25 June, 2022
    Covid-19 vaccines
    BioNTech/Pfizer say Omicron-targeting boosters elicit strong immune response

    New vaccine candidates significantly outperform existing Covid jabs at targeting the most prevalent strain

  • Friday, 24 June, 2022
    Roe vs Wade
    US Supreme Court ruling triggers rush of new restrictions on abortion

    Providers of the procedure scramble as Republican-led states enact pre-planned bans while others consider their own moves

  • Friday, 24 June, 2022
    Roe vs Wade
    US business treads cautious line after Supreme Court abortion ruling

    Companies offer to pay travel expenses for procedure but most refrain from taking sides

  • Friday, 24 June, 2022
    The FT ViewThe editorial board
    Living with Covid-19 requires caution, not complacency

    Governments need to plan now for what could be a tough autumn

  • Friday, 24 June, 2022
    Covid-19 vaccines
    Sanofi-GSK Covid vaccine found effective against Omicron

    Pharma companies are hoping to catch up with rivals as they report promising trial results for jab

  • Thursday, 23 June, 2022
    Coronavirus treatment
    UK prepares to include over-50s in autumn Covid booster campaign

    Javid says he asked officials to revise previous plans that would exclude under-65s

  • Thursday, 23 June, 2022
    Coronavirus pandemic
    Flu epidemic risks sweeping China left vulnerable by zero-Covid fixation

    Xi Jinping orders public health policy to prioritise Covid control over all other diseases

  • Wednesday, 22 June, 2022
    Medical science
    Poliovirus detected in London sewage samples

    UK health agency investigating possibility of community transmission says risk to public ‘extremely low’

  • Wednesday, 22 June, 2022
    Moderna
    Moderna calls for approval of two-strain Covid vaccine booster

    US biotech group says shot targeting both first strain and Omicron could help avert ‘large rise’ in cases

  • Wednesday, 22 June, 2022
    Covid-19 vaccines
    UK signs £1bn deal with Moderna for new vaccine centre

    Government seeks to secure domestic jab supply and prepare for future pandemics in deal with Boston biotech

  • Wednesday, 22 June, 2022
    Biotech
    Biotechs face ‘funding Sahara’ as easy money runs dry

    Early-stage drugmakers face difficult decisions as public markets turn hostile

  • Tuesday, 21 June, 2022
    Behind the Money podcast28 min listen
    Inside Johnson & Johnson’s bankruptcy two-step

    This legal manoeuvre is setting a new precedent for corporations to evade accountability in America

  • Monday, 20 June, 2022
    Uhuru Kenyatta
    President Kenyatta: We need vaccines and investment to tip the scales against malaria

    After years in retreat, the disease is once again on the rise across the continent

  • Monday, 20 June, 2022
    Pfizer Inc
    Pfizer buys stake in French vaccine maker Valneva

    US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme

  • Saturday, 18 June, 2022
    Covid-19 vaccines
    US CDC recommends Covid vaccines for children under 5

    Children as young as six months old can begin receiving Pfizer or Moderna vaccines as soon as Monday

  • Saturday, 18 June, 2022
    Covid-19 vaccines
    BioNTech chief calls for speedy ruling on Covid vaccines that target latest strains

    ‘Time is ticking’ as studies suggest original Omicron jabs may not offer strong protection against sub-variants

  • Thursday, 16 June, 2022
    Covid-19 vaccines
    WHO set to back use of Covid variant-specific vaccines as third shot

    Recommendation by health agency advisory group marks shift in thinking of global health authorities

  • Thursday, 16 June, 2022
    Medical science
    Charity launches £80mn programme with US partner to address cancer challenges

    Cancer Research UK will eventually spend £295mn with National Cancer Institute on projects to understand and prevent tumour growth

Previous page You are on page 1 Next page

Topics related to Health & pharmaceuticals

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In